Compare MDXH & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MDXH | ICMB |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | | Finance: Consumer Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.1M | 17.2M |
| IPO Year | 2021 | 2013 |
| Metric | MDXH | ICMB |
|---|---|---|
| Price | $0.40 | $0.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.67 | N/A |
| AVG Volume (30 Days) | ★ 470.6K | 80.2K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 21.74% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.78 | $7.43 |
| Revenue Next Year | $18.31 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.40 | $0.73 |
| 52 Week High | $5.33 | $3.12 |
| Indicator | MDXH | ICMB |
|---|---|---|
| Relative Strength Index (RSI) | 31.72 | 31.04 |
| Support Level | N/A | $0.73 |
| Resistance Level | $3.79 | $1.29 |
| Average True Range (ATR) | 0.03 | 0.06 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 5.07 | 23.58 |
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). The investment objective of the company is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.